Surgery Partners has rejected a take-private offer from its largest shareholder, Bain Capital, after failing to reach agreement on deal terms.

The decision follows a comprehensive review by a special committee of independent directors, which concluded that the company is best positioned to deliver value by remaining publicly listed.

In January, Bain Capital had proposed acquiring the remaining shares of Surgery Partners it does not already own for $25.75 per share. Bain currently holds a 38.97% stake, according to LSEG data. The announcement sent Surgery Partners’ shares down more than 13% in pre-market trading to $20.10.

While Bain has not issued a statement following the rejection, the firm remains a key stakeholder in the company’s future direction. Industry reports also suggest prior interest in Surgery Partners from other strategic and financial investors, including TPG and UnitedHealth Group.

Despite turning down the offer, Surgery Partners reaffirmed its commitment to its standalone growth strategy. The company maintained its full-year revenue guidance of $3.3bn to $3.45bn – aligned with analyst estimates – and plans to host an investor day in the second half of 2025 to outline its long-term outlook.

The development highlights the resilience of private equity interest in healthcare services, with Bain’s continued engagement positioning it to influence the company’s future strategic moves.

Source: Reuters

Can`t stop reading? Read more.